EUVIMED · CrossrefZeitschrift
Intestinal Research
ISSN 1598-9100 · Korean Association for the Study of Intestinal Diseases
Neueste Artikel
Clinical profiles and management strategies in older adults with mild-to-moderate ulcerative colitis: a multicenter, comparative, real-world study
The role of the Mediterranean diet in the management of inflammatory bowel disease: a narrative review
The impact of inflammatory bowel disease on women’s health: a cross-sectional study in India
Diagnosis of intestinal tuberculosis: a systematic review and meta-analysis
First-line biologic therapy selection highly impacts ulcerative colitis outcomes: results from the APPETISER study
Colitis-associated colorectal neoplasia in ulcerative colitis with primary sclerosing cholangitis: a nationwide study
Evaluation of the Mayo endoscopic score in ulcerative colitis using a multimodal large language model: a human-blinded accuracy study
Efficacy and safety of filgotinib in the treatment of ulcerative colitis with a focus on rapid and sustained efficacy: a narrative review
Safety and effectiveness of budesonide rectal foam for ulcerative colitis in a large-scale, multicenter, prospective observational study: final report of post-marketing surveillance in Japan
Efficacy and safety of mirikizumab in maintenance therapy for ulcerative colitis in difficult-to-treat inflammatory bowel disease: a single-center retrospective study in Japan
Impact of Portulaca oleracea L. extract in patients with irritable bowel syndrome
Clinical usefulness of fecal calprotectin in assessing disease activity and endoscopic remission in intestinal Behçet’s disease
Biology and preclinical models of colorectal cancer metastasis
Integrated endoscopic and medical approaches for Crohn’s disease-associated strictures
Comments on “Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study”
Chinese expert consensus on extraintestinal manifestations of inflammatory bowel disease
Primary sclerosing cholangitis and ulcerative colitis-associated neoplasia in Asia: optimizing beyond risk recognition
Beyond first-line biologic therapy: does treatment sequence matter in ulcerative colitis?
Comparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study
Burden of inflammatory bowel disease in India: analysis of the Global Burden of Disease study from 1990 to 2019
Peroxisome proliferator-activated receptors in inflammatory bowel disease: linking immunometabolism, lipid signaling, and therapeutic potential
Propensity score-matched real-world comparative treatment outcomes of Janus kinase inhibitors for ulcerative colitis in patients with and without prior exposure to anti-tumor necrosis factor α antibody
Targeting the gut microbiome in inflammatory bowel disease: from concept to clinical reality
Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease
Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study
Predictive accuracy of fecal calprotectin for histologic remission in ulcerative colitis
Filgotinib induction-study baseline characteristics of patients with ulcerative colitis who achieve sustained corticosteroid-free remission: post hoc analysis of the phase 2b/3 SELECTION study
Perianal fistulizing lesions of Crohn’s disease are associated with long-term behavior and its transition: a Chinese cohort study
The practice of fecal microbiota transplantation in inflammatory bowel disease
EUVIMED